(Q39285185)

10 September 2017

title

Niraparib: First Global Approval (English)

1 reference

10 September 2017

1

Lesley J Scott

1 reference

10 September 2017

publication date

4 May 2017

1 reference

10 September 2017

1 reference

10 September 2017

volume

77

1 reference

10 September 2017

issue

9

1 reference

10 September 2017

page(s)

1029-1034

1 reference

https://scigraph.springernature.com/pub.10.1007/s40265-017-0752-y

10 September 2017

exact match

0 references

cites work

Niraparib: A Poly(ADP-ribose) Polymerase (PARP) Inhibitor for the Treatment of Tumors with Defective Homologous Recombination

1 reference

https://api.crossref.org/works/10.1007%2FS40265-017-0752-Y

PARP Inhibitors in Reproductive System Cancers: Current Use and Developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-017-0752-Y

Discovery of 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): a novel oral poly(ADP-ribose)polymerase (PARP) inhibitor efficacious in BRCA-1 and -2 mutant tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-017-0752-Y

Niraparib (MK-4827), a novel poly(ADP-Ribose) polymerase inhibitor, radiosensitizes human lung and breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-017-0752-Y

MK-4827, a PARP-1/-2 inhibitor, strongly enhances response of human lung and breast cancer xenografts to radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-017-0752-Y

Human mass balance study and metabolite profiling of 14C-niraparib, a novel poly(ADP-Ribose) polymerase (PARP)-1 and PARP-2 inhibitor, in patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-017-0752-Y

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-017-0752-Y

Poly (ADP-Ribose) polymerase inhibitor MK-4827 together with radiation as a novel therapy for metastatic neuroblastoma

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28474297

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S40265-017-0752-Y

1 reference

10 September 2017

1 reference